Wisdom of medical analysis of IBM medical information sharing technology

12 March, IBM announced that it will create a set of Guangdong provincial hospital new medical information sharing and analysis system, traditional Chinese and modern Western medicine.

The CHAS (medical and health records, analysis and sharing) system is designed to help achieve clinical data included and Western electronic medical record information sharing.

Because of the medicine in theory, diagnosis and treatment on a big difference, IBM has overcome the many technical challenges to help in the various departments of the hospital yuanbu and complex medical data between integration and information sharing.

The core of this solution is based on standardized clinical information model, it can in the various departments of the hospital between efficient information sharing, and eventually also with the hospital outside other medical institutions for information sharing.

CHAS by clinical Chinese and Western all kinds of information integration into a standardized, computable model, making it possible to use advanced data analysis techniques, thus contributing to the medical staff provides a method that can be tailored to specific diseases and patients, have gained a deeper understanding of the different methods according to traditional Chinese and Western medical plan and technology which is optimal.

Ultimately, the integration of information also helps medical personnel for the development of fusion of Western treatment plan.

CHAS is IBM's latest innovations, help in the world for more intelligent, interconnect, based on open standards of the medical information system.

IBM in the United States to Institute scientists in close collaboration with the design and implementation of the system, the system incorporates IBM advanced semantic technologies. This semantic technology can cause the system to understand and analyze specific clinical records the exact meaning of the content, CHAS also can handle different kinds of language used, the medical records of all information, regardless of format, terminology, or language that can be processed into a standardized documentation. This will allow hospitals, end and hospital external medical institutions information sharing easier.

China National Ministry of health select Guangdong provincial hospital as national key Chinese medical and scientific bases.

Founded in 1933 by Guangdong provincial hospital in Western medicine is recognized as a leader, is a blend of medical services, scientific research and teaching as one of the institutions. As southern China's largest hospitals, medical patients every day for more than 1 million people, approximately 400 000 patients admitted.

Guangdong provincial hospital, Mr. Lu Yu said: "our hospitals have long-term tradition of excellence, not only in medical side, in terms of scientific research and teaching.

We are committed to maintaining high standards, IBM CHAS technology help us do this, while IBM clinical information integration technology helps hospital information system from the non-convergence of applications into a consolidated, patient-centric system. ”

Throughout Guangdong provincial hospital system, CHAS: patient-centered health information management and sharing system, provides an open, standards-based, interoperable electronic medical record solution; contribute to the standardization of medical records, greatly facilitate medical analysis, medical research and clinical quality control to provide data base; can help implement a cross-sectoral and cross-regional medical patient record sharing between agencies, improving the efficiency of medical services; for medical information industry achieve internationally recognized standards reduce technical threshold.

IBM greater China Group Chief Technology Officer and head of IBM China research lab, Dr. Li Shi Gong said: "in the digital age, the individual hospital found that manage and share information is becoming more and more difficult, simply because more than ever, generated more data.

We create and implement these innovative technologies that will make medical systems smarter, more efficient, more accessible and more affordable. ”

Since CHAS is built on open, internationally accepted standards of technology, this system is also able to expand the use of electronic medical records, supporting clinical information in depth analysis, helps to promote global health sector at the forefront of research and innovation.

In late 2007, IBM announced its cooperation with the Chinese Ministry of health, through a system based on open standards and information sharing technology platform, enhancing regional medical services quality.

China hopes to promote in all hospital electronic medical records and medical data analysis, to alleviate the burden on patients, decide who should receive priority treatment and more efficient use of resources. For example, the daily inspection and easy treatment available in community hospitals, while more complex health problems and treatment may be recommended to see a specialist. CHAS would also help to support and promote the implementation of the plan, and has the potential to push the country's medical system reform forward.

The State Council has recently adopted a national health care reform programmes, including the 2011 will spend $ 8500, on all Chinese people provide general medical services.

In the United States has had a similar plan, the Obama administration plan in 5 years on medical information technology investment of us $ 20 billion, for national computerization of medical records.

IBM through scientific research and cooperation with the medical institutions to improve the medical records, dating back to the 1950s.

In the last 10 years, IBM and the United States together with the University of Pennsylvania has developed a nationwide digital breast x-rays archives system; and Mayo hospital jointly developed clinical trial participants system; and Scripps cooperative research influenza virus is how variability and proactively develop treatment method; and European universities to develop better treatment for AIDS; create a "world community grid", cancer, AIDS, dengue fever and other diseases.

Our arrangements billion earmarked funds, prevention and control of influenza a (H1N1)

Recently, Premier Wen Jiabao hosted a State Council Executive meeting to hear the previous phase of the influenza a H1N1 influenza prevention and control research and reporting further control measures.

The Conference notes that current, prevention of influenza a (H1N1) outbreak in a crucial stage.

Outside the outbreak has developed into more than 20 countries and regions, China must maintain vigilance should never be taken lightly.

Session, to further improving the ten key areas of work: (a) continue to strengthen the entry-exit inspection and quarantine.

This outbreak occurred outside the current priority is to tighten immigration and quarantine. To come from the epidemic countries and regions of the immigration officer strict medical investigation and tracking medical investigations, from the area of transport and goods implemented strict disinfection, quarantine, the various measures do fine do it, there can be no omissions. (Ii) to strengthen surveillance work. Strictly implement outbreak zero reporting system, discover the epidemic must be timely and accurate reporting, and will never allow huanbao, hidden and false negatives. (C) preparations for medical treatment. Everywhere you want to specify the specialized treatment hospital, to ensure that once you find patients, can prompt isolation, examination, diagnosis and treatment. (4) making emergency materials production and reserves. To organize and quarantine inspection equipment, protective vaccination supplies, effective anti-retroviral drugs and treatment apparatus, material production and reserves, in case you need it. (5) active control technology of scientific research. To focus and accelerate the influenza a H1N1 Influenza Pathogenesis, monitoring technologies, vaccines, clinical management, effective antiviral drug research, and strive to achieve new results as soon as possible. To play in traditional Chinese medicine in prevention work. (6) with the relevant national and international organizations to actively collaborate with, the establishment of mechanisms, conducts scientific research, prevention and control techniques, information exchange, cooperation, is in need of countries and regions provide financial, material and technical support. (VII) improving swine and poultry and other animal influenza surveillance and control. On swine and poultry farming in concentrated areas and farms, slaughterhouses, trading markets, and to focus on animal influenza epidemic monitoring and surveys, strict quarantine supervision. (8) in order to safeguard the prevention and control, the central financial arrangements billion earmarked funds. Local levels, the financial allocation of funds to. (IX) promote education and information to the public. Strengthening disease knowledge popularization, let the masses learn about influenza a (H1N1) is to prevent, controllable, treatable, timely perplexities for masses. To establish a strict information public release system, the first time in a timely and accurate manner to publish the latest information at home and abroad to enhance the transparency of the prevention and control, correct guide social media. (10) in patriotic health campaign to promote physical fitness, enhance national physical fitness and good health habits.

Carbon and oxygen Masimo on pulse oximetry new era

7 April, the Vatican's industrial co., Ltd. Shanghai organized about Masimo Radical-7 pulse, carbon and oxygen oxygen measuring user experience Conference.

At the Shanghai major hospitals in clinical studies, first aid, Anesthesiology 100 's together, on the "pulse of the hemoglobin monitoring and variation index monitoring progress" in conducting a heated discussion, Zhongshan hospital Anesthesiology Xue Zhang gang Professor, chaired the meeting.

From masimo Corporation of Angela, also at the meeting and introduce the masimo Corporation products and ideas, she said with more than 200 patents masimo Corporation has focused on human health.

Masimo Radical-7 pulse, carbon and oxygen oxygen measuring instrument is the world's first use of Masimo Rainbow SET technology-bedside monitor. Masimo Rainbow SET to launch in the United States in 2005, is the world's first and only FDA approved at the non-invasive continuous monitoring of carboxyhemoglobin (SpCO), iron and hemoglobin (SpMet), oximetry (SpO2), blood perfusion index (Perfusion Index) and pulse rate technology. For non-invasive measurement SpCO and SpMet provides unprecedented tool.

Ruijin hospital emergency Department of Professor Lu Ming, first of all to "blood hemoglobin and continuous monitoring in first aid and ICU of" as its theme for a special report.

Lu Professor shared trauma, and the accurate measurement of the oxygen balance and hemoglobin changes value is ideal for detecting trauma patients. He expressed the pulse oximetry monitoring of carbon and oxygen requires non-invasive, continuous, real-time, and Masimo Radical-7 enables non-invasive is, continuous, real-time these three standards. Masimo Corporation in 2007, the first episode of the Pleth variation index (PVI), in 2008 the first total hemoglobin (SpHb), Professor Lu, PVI fluid management in reducing postoperative risks, improve the prognosis, reduce heart lung complications and promote wound healing has considerable value. He also affirmed the value of the PVI, PVI is ideal for non-invasive monitoring tools, can be widely used in first aid, operating room and ICU. PVI could help doctors to optimize fluid management and improve treatment outcomes.

First people's Hospital, Professor of Anesthesiology foot pass and shared "hemoglobin monitoring and rational use of blood," he said to experience loss of treatment goals: maintaining circulation capacity; keep the oxygen carrying capacity; restoration of blood coagulation and inner environment.

Professor Li focused major surgery before and after serious patients hemoglobin monitoring, he thought the first Masimo Corporation in 2008 the total hemoglobin (SpHb) non-invasive monitoring as disease with severe illness estimated prognosis indicators, to strengthen major surgery with severe illness of control is of great significance.

Ruijin hospital anesthetic, Professor, Director of the cloth is made a summary of the workshop, he hoped that the various departments of the chief physician is not satisfied with the status quo, active learning of new technologies and new equipment.

Should have the courage to innovate, in medical posts a line on its own.

Based on ARM core of single realization of ECG testing module

As the clinical application of the electrocardiogram and the development of electronic technology, ECG as biomedical measurement in a more mature, more extensive technical, has gradually become a general clinical examination, and heart disease diagnosis, care, and pharmacology of played a very important role.

Current common ECG detection circuit for dual supply, this scenario requires a lot of power devices and large route, which will increase the cost of the product. This paper presents the design uses single supply, you can resolve these problems, and reduce product costs, while the design is also based on ARM core embedded system using a simple and practical algorithms that can quickly and accurately locate QRS complex wave (that is, man's heart rate). The design for the home user, small size, just need a personal computer connected to real-time operation and observation of the ECG.

ECG signal acquisition system's basic structure as shown in Figure 1.

The body of the ECG electrodes and dedicated lead wire from the human body sent to the system. By filtering and amplifying weak regulation circuit, ECG signal is amplified to a suitable value, and in A/D conversion.

Figure 1: ECG signal acquisition system infrastructure.

System control and data processing by ADI ARM7 TDMI kernel based MCU ADuC7020.

This chip has a wealth of on-chip peripheral circuits, processing speeds up 40MIPS, A/D conversion rate of up to 1MSPS, with very high performance-price ratio. Final results from the UART port ADuC7020 through to the computer, the computer through an interface by LabVIEW to write the results visually displayed or stored. Figure 2 is the basic hardware circuit diagrams.

Figure 2: basic hardware circuits.

From the human body or ECG signal generator on acquisition to the ECG signal amplitude between the 0.05 ~ 5mV (normally 2mV), frequency between the 0.05Hz ~ 75Hz.

ECG to buffered, matching resistor network, voltage amplifier and filter circuit, and several levels.

ECG first after a two-level RC low pass filter, into the buffer level.

Signal before entering the system, you need to get rid of high frequency components, so here's a cutoff frequency for 300Hz's low pass filter, to ensure 0.05 ~ 75Hz faint ECG not decay. Buffering level consists of a voltage follower components, which can enhance the entire amplifier input impedance, lower output impedance. In order to guarantee the consistency of the differential signal, should use integrated on the chip of the amplifier. Matched resistor networks typically use Wilson power Center side network that uses a specific electrical resistance network access Wilson Center side as the entire ECG system of reference point.

Filter amplifier with front-stage amplifier with differential negative feedback, use the ADI adjustable gain high common-mode rejection ratio of instrumentation amplifier AD8221 as front-stage amplifier.

The magnification is set to 8 times, by the formula k G = 49.4 Ω/R G + 1 calculated that RG is AD8221 two RG pin resistance value between.

The resistor should adopt high accuracy, low drift of metal film resistors, to ensure low noise performance AD8221.

AD8221 ref no grounding pin, which is a low-pass filter and constitute a negative feedback loop, so that we can effectively filter out the DC component, so that the voltage U1 Department are always clamped in 1.25V. Because it is a single supply, and different-lead ECG signal voltage there is a negative, so be sure to provide a suitable clamping voltage. ADuC7020 ad conversion mode voltage input range is 0-2.5V, here select intermediate values 1.25V as clamp voltage.

AD8221 output of single-ended signal amplitude is very small, mixed with a large number of interference for data processing.

After the class filter amplifier gain from a larger Active lowpass, adjustable gain. Different people is not the same as ECG signal strength, taking into account the attenuation, the gain is set to 150 times. System's transfer function is:

The two low-pass filter requires a low voltage offset, low temperature drift and low-noise characteristics, ADI's rail-to-rail input output dual operational amplifier AD8607 well meet these requirements.

As a result of the second level amplifier is RP-input, so the resulting signal is inverted, that can be made in the software.

From protecting patients and improve the system in terms of common-mode rejection ratio, common-mode signal must be reversed and zoom, and then back to the human body, so that the system and the body will comprise a voltage shunt negative feedback network, commonly referred to as the right leg drive circuit.

By ADuC7020 on the ECG for AD conversion, select the timer control in the ADC sampling mode. Once A/D conversion end interrupt trigger ADC, the interrupt service program on digital signal processing.

Handle the ECG signal lies on the ECG in the QRS complex wave of precise identification.

Normal QRS complex of width 0.06 to 0.10 seconds, and is not controlled by rhythm changes. For R-wave is very sharp features, we passed a sliding window determine signal peak and Valley meets the requirements, while acknowledging its whether time window. The signal amplitude threshold thresholding using double variable, which is set on a wave crest and trough threshold. If the peaks and valleys threshold in a reasonable time has a larger change, reset Peak threshold and Valley threshold. Here we will use the QRS complex wave positioning and arrhythmia calculation. On the start time of the signal only for RP and filter processing, this is to be inverted to recover of ECG andAvoid signal early fluctuations threshold. And then in a certain period of time, according to the sample data set Peak threshold Thpeak and Valley threshold THtrough and QRS positioning. Finally, follow the steps below (see Figure 3) for data processing.

Figure 3: the basic steps for data processing.

Read new sampling point Ni:

1) judgment sampling point of signal amplitude value is greater than Peak threshold Thpeak.

If not, go back to step 1).

2) If a condition is satisfied, the start count n = 1, and record the n value is peaktime1.

The time window starting side slip here.

3) continue to sample Ni + 1 per sampling time then n + 1.

4) judging new sampling point Ni + 1 is less than Valley threshold.

If not, go back to step 4).

5) if the sampling point is less than the threshold Thtrough, the Valley of the point of the n value is troughtime1.

6 judge both meet the amplitude of the signal point requirements at all times the difference between peaktime1 troughtime1 and whether a time window, which is less than the window width THtime.

If not less than THtime, return to step 1).

7) If true, then the signal is considered a QRS complex.

Peaktime1 is positioned as one of the R wave.

The position of the R wave, on the basis of statistical heart rate by following these steps: 1) to locate the first R-wave, and record the n value is peaktime1; 2) found the second R wave, and record the n value is peaktime2; 3) in accordance with the following formula to calculate the rhythm.

Practice has proved that with this algorithm the calculated rhythm accuracy is high, the calculation is simple, easy to implement, and eventually on PC observed ECG waveform and rhythm values.

Perspective of the ABCD IV medical device, look for the electronic technology for maximum value-

Electronic technology's contribution to medical science is obvious to all, who can envision the physician doctor without the aid of medical electronic devices is what status? e technology, extended or save human life for electronic engineer sense soar; at the same time, be able to make use of the medical industry is increasingly weak profits of electronic products to inject more added value is also extreme concern to manufacturers '.

Due to human security will have a direct or indirect impact on medical device product classification is set, the global coordination of the working group to develop a world wide standard medical equipment is divided into the following A, B, C, D grade: 4

A-level refers to when a failure occurs, the harm to the human body produces very low product, such as x-rays, scalpel, tweezers, stainless steel small appliances, and surgical non-woven cotton wool, gauze, medical, and surgical knife lighting equipment, special apparatus and Stomatology surgery microscope, home first aid bandage;

B level means less harmful products such as blood analyzers, x-ray diagnostic equipment, medical CT, ultrasound, magnetic resonance imaging (MRI), electronic thermometer, electronic sphygmomanometer, electronic stethoscope, electromagnetic blood flow, heart rate monitor, ECG, EEG, EMG, vital capacity meter, electronic lung capacity meter, Oximeter, endoscopy, Capsule Endoscope, blood cell counter, oxygen, low-frequency infrared treatment instrument, medical equipment, microwave treatment instrument, ultrasonic therapy equipment, home electronic Massager, hearing aids, etc.;

C is more risky products, such as continuous blood glucose meter, dialyzer, artificial heart lung machine blood pumps, ventilators, implanted hearing aids, heart defibrillator, extracorporeal cardiac pacemaker, infusion pumps, selves testing glucose meter, etc.

D is the implantable cardiac pacemaker, implantable defibrillators, implantable syringe, implantable aided artificial heart system high risk products.

In this four-level, B, C, D-level needs to be involved in electronic technology, and obviously, the higher the risk level of the product on electronic technology requirements are higher, appropriate, and constantly update the breakthrough of electronic technology to drive the few areas of innovation.

Higher accuracy, smaller medical imaging

A combination of optical, electronic, biomedical technologies, Biomedical Optics in B-class medical-grade equipment is very wide, and covers the optical treatment, medical imaging and Bio-sensing, main applications include clinical lesion of early diagnosis and monitoring, or light guide, inspire-related diseases.

It is estimated that sales of related products for the year 2010 is expected to achieve global 598 billion, accounting for 22% of medical equipment.

From a specific product, from the x-rays, magnetic resonance imaging (MRI), Masako tomography Imaging (PET), CT, ultrasound, radiotherapy, Photodynamic therapy, physiological signal monitoring, in vitro diagnostic and biochips are included in the areas of bio-medical electronics.

The application of the previous types of imaging technology is the overall medical technology market share of the largest areas of development is more mature and competitive, as market demand gap, not only renowned international manufacturers and local manufacturers competition is quite intense, more manufacturers are constantly trying to enters that area.

Continuously improve the resolution and continuously reduce the volume of the device is a medical imaging two major trends in the field of the new system-on-demand means that the analog semiconductor manufacturers have developed ground-breaking Foundation IC, active semiconductor manufacturers to introduce their products, such as TI for ultrasonic imaging applications AFE58XX analog front end series, ADI for CT applications by Xilinx and Altera ADAS1128, etc for high-resolution image processing and high performance data analysis of FPGA, Austria microelectronics for DR and CT applications of high precision amplifier and sensors.

In addition to using optical imaging technology, innovation can be ingested by endoscopy (also known as capsule endoscopy) broke the inherent shortcomings of conventional endoscopy, which can effectively be human image back to the outside.

Latest capsule endoscopy to sensors and circuits placed in capsules, when patients swallow the capsule will after in vivo and 360 ° rotation, plus the circuit containing for lighting of the led, can be effective in vivo images back to the external device. But the technology is still in its infancy, the future of universal also need cost and performance improvements.

Science fiction-like legendary implantation techniques

Let the MEMS applications fiery is consumer electronics, medical and diagnostic equipment for MEMS applications provides a larger arena.

More and more applications creativity will MEMS technology and medical perfect together, and thus the benefit of mankind. Than the Ruyi method Semiconductor for Switzerland Sensimed AG designed a MEMS sensor embedded wireless, embedded with a contact lens micro strain gauge continuously over a period of time (usually 24 hours) monitoring the curvature of the eyes, in addition to the lens also embedded antenna, mini specialized processing circuits and sent to the receiver RF transmitter measurement data.

In the application of bio-medical MEMS has also been in actual growth in clinical medicine use sensors and intelligent control technology for the treatment of pulmonary tuberculosis and heart disease, heart of incentives and dredging.

Innovation application including a revolutionary Proteus Biomedical company: implanted electrodes, it can stimulate the heart within different cavity location make them for synchronization or synchronization heart treatment. Its core technology is manufactured using a chip scale package technology, mm level dimensions of MEMS sensor and processor packaging system in the body's internal use, and can be maintained for many years, to avoid the traditional must use more insert catheter to stimulate the heart of different locations.

Implantation techniques like science fiction as legend, belonged to the risk level of C and D class equipment.

The implantation of the product categories for heart disease treatment and next will focus on in the brain, such as electronic nerve stimulation device therapy from drug addiction to epilepsy, Parkinson's disease and depression and other disorders.In fact, at this stage the world about one third of the health problems associated with neural areas. Large Medtronic pacemaker companies have developed for the treatment of Parkinson's and other minor diseases of equipment, and is developing a series of neural implant products.

Dependent on the progress of electronic technology, global medical electronics field are examples of the continuing innovation, future medical and Electronics will more closely, thus creating a stronger, more innovative medical devices.

Our heavy ion deep cancer therapy clinical trial study starts

Recently, in the shallow tumor therapy clinical trial success based on the Chinese heavy ions in the treatment of cancer has made new progress, deep cancer therapy clinical trial study in modern physics, Chinese Academy of Sciences.

As of April 3, already have signed more than patients in clinical trials began in zhiyuanshu based in modern physics, Chinese Academy of Sciences of the Gansu province in heavy ion beam therapy cancer clinical research base to begin treatment. "The clinical trials still by Chinese Academy of Sciences Institute of modern physics and Lanzhou in Gansu province Cancer Hospital, Lanzhou Institute and other medical institutions, and the original combination of depth less than 2.5 cm of shallow cancer treatment trials, this is the depth of greater than 2.5 cm deep cancer clinical trials. "Modern physics, Chinese Academy of science and technology Deputy Commissioner Huzheng countries said. In November 2006, the Chinese Academy of Sciences Institute of modern physics and local health agencies to begin heavy ion shallow tumor therapy clinical trial research. Huzheng States that "has a 8 103 cases of shallow cancer clinical trials, efficacy was significant, indicating that the Chinese in heavy ion superficial treatment of human cancer clinical trial on the initial success. "In 2008, the new heavy-ion accelerator of Lanzhou cooling storage ring provides high energy heavy-ion beam treatment of deep tumor treatment Terminal in Chinese Academy of Sciences Institute of modern physics is built, and completed a beam test and the first cell and animal studies. Recently started heavy ion deep cancer therapy clinical trial research is on that basis.

Treatment of malignant tumours is haunting the world challenge.

Doctor of general use, though in the radiotherapy of cancer treatment on some show good results, but there is an obvious side effect, but in the course of treatment, will give the affected the surrounding healthy tissue causing greater damage. Unlike traditional radiation therapy for cancer e, X, compared to conventional x-ray, heavy ion beam with radiation damage to healthy tissue, the treatment course short, light cure rates high.

International advanced medical electronic technology is accelerating development (1)

Imagine this scene: a heart disease in the lungs is constantly producing effusion, this is the early symptoms of heart failure.

While the patient of an implantable sensor medical equipment through a Bluetooth enabled mobile phones at the same time with the patient and his doctors send signals to remind potential danger. Daydreaming?. This technology actually exists and is constantly improving, and the lack of a support infrastructure.

InCube company founders Mir Imran recently in Las Vegas 2009 International Consumer Electronics Show (CES) in a medical electronic discussion groups described above.

The participants discussed the implantable device of great potential, they can precisely and quickly monitoring and treatment is located anywhere in the world of chronic * disease patients, such as heart disease, epilepsy, diabetes and Parkinson's syndrome, etc.

In addition to the sensor implant, there are many more steps to improve people's health-care level.

Like insulin pumps and other equipment are already very mature, can offer services for all organs. Implantable Visual systems have also made significant progress. Micro electro mechanical systems (MEMS) and carbon nanotubes (CNT) nervous system implantation is providing human how to conduct large amounts of information.

Used for the diagnosis and treatment of many health problems of tools are being rapidly improved.

Some surgical instruments can be accessed through the catheter body almost every section. Sustained-release drug capsules are becoming more efficient, and enhanced diagnostic and therapeutic effect. External device can be worn on the treatment of applications is also very important, and lab-on-chip devices can quickly sampling, diagnosis and reporting of important medical tizheng patients.

Healthcare technology can meet the emergency needs.

Worldwide approximately 80% of healthcare costs for treatment of chronic diseases of the elderly. Approximately 6 million patients suffer from chronic diseases, such as chronic obstructive pulmonary disease (COPD), congestive heart failure and epilepsy-mental disorders etc. Longer life, lack of health care professionals and health care costs spiraling makes the situation worse.

"Single United States healthcare market on tat 2.5 trillion.

"Diamond Management & Technology Consultants company analyst Andrew Rocklin said," anyone not want to participate in this market will lose significant revenue potential. "But the effectiveness of the techniques demonstrated before a series of obstacles must be overcome, one of which is the healthcare system, including the United States and around the world, the need for a thorough reform.

Diabetes and heart disease Papuans

Debiotech company and ST (STMicrolectronics) jointly announced the company has developed the first disposable insulin pump Tablet prototype (Figure 1).

The use of Microfluidic MEMS technology of nano-pump has passed the initial testing stages, and since last summer started the mass production. Its size is the original one-fourth of the insulin pump equipment, worn on the skin is almost invisible.

This Nano pump use of continuous subcutaneous insulin injection (CSII) technology perfectly simulate the secretion of insulin by the pancreas, the simultaneous detection of naturally affect patient safety potential pump failure.

According to the two companies, and several times a day you must make separate insulin injection, it costs less, is a more attractive alternative technologies.

University of Michigan researchers Mark Meyerhoff is helping United States * military research laboratory develops implantable glucose sensor of subcutaneous, this sensor can real-time monitoring diabetes symptoms.

His use of polymers to the birth of low concentration of nitric oxide. As a surgical implant type current meter glucose sensor outer envelope, these materials have better bio-compatibility, because they can reduce the implantation of inflammation caused by the sensor. Cardiovascular disease is the cause of death and disability of the common factors. United States-third of deaths by including arrhythmia, heart disease, which would also encourage people to develop medical monitoring equipment and tools. Belgium IMEC company design wireless electrocardiogram (ECG) disk monitor is a device (Figure 2).